MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹207 Cr | ₹493 Cr | ₹670 Cr | ₹372 Cr | ₹313 Cr |
What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹207 Cr |
Mar2023 | ₹493 Cr |
Mar2022 | ₹670 Cr |
Mar2021 | ₹372 Cr |
Mar2020 | ₹313 Cr |
How is Capital Work in Progress of MANKIND PHARMA Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹207 Cr | -58.01 | |
Mar2023 | ₹493 Cr | -26.38 | |
Mar2022 | ₹670 Cr | 80.26 | |
Mar2021 | ₹372 Cr | 18.63 | |
Mar2020 | ₹313 Cr | - |
Compare Capital Work in Progress of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹102,282.7 Cr | 0.9% | -3.4% | 37% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -2% | -6.1% | 49.9% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 0.9% |
-3.4% |
37% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses